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Background: The segmental relationship between cardiovascular magnetic resonance (CMR) peak circumferential strain
(Ecc) and myocardial scar has not been well characterized in Duchenne muscular dystrophy (DMD), and it is unknown
whether echocardiography accurately measures Ecc in DMD. We assessed segmental Ecc and scar using CMR with
myocardial tissue tagging and late gadolinium enhancement (LGE) in patients with DMD, then compared CMR with
echocardiographic velocity vector imaging (VVI) for regional Ecc based on independent observer assessments.
Results: Participants enrolled (n = 16; age 8-23) had median left ventricular (LV) ejection fraction of 0.52 (range
0.28-0.69), and 156 basal and mid-cavity myocardial segments from the 13 patients completing the LGE protocol
were analyzed for strain and scar. Segmental CMR Ecc in the most negative quartile (quartile 4) ruled out scar in
that segment, but scar was present in 46% of segments in the least negative (most dysfunctional) Ecc quartile 1,
33% of Ecc quartile 2 segments, and 15% of Ecc quartile 3 segments. Overall scar prevalence in inferior,
inferolateral, and anterolateral segments was eight times higher than in inferoseptal, anteroseptal, and anterior
segments (p < 0.001). This increased proportion of scar in lateral versus septal segments was consistent across CMR
Ecc quartiles (quartile 1: 76% versus 11%, p = 0.001; quartile 2: 65% versus 9%, p < 0.001; quartile 3: 38% versus 0%,
p < 0.001). Echocardiographic analysis could be performed in 12 of 14 patients with CMR exams and had to be
limited to mid-cavity slices. Echo segmental Ecc in the most negative quartile made scar by CMR in that segment
highly unlikely, but the correlation in segmental Ecc between CMR and echo was limited (r = 0.27; p = 0.02).
Conclusions: The relationship between scar and Ecc in DMD is complex. Among myocardial segments with
depressed Ecc, scar prevalence was much higher in inferior, inferolateral, and anterolateral segments, indicating a
regionally dependent association between abnormal Ecc and scar, with free wall segments commonly developing
dysfunction with scar and septal segments developing dysfunction without scar. Although normal
echocardiographic Ecc predicted absence of scar, regional echocardiographic Ecc by VVI has only a limited
association with CMR Ecc in DMD.
Background
Duchenne muscular dystrophy (DMD), the most com-
mon of the muscular dystrophies, with an incidence of 1
in 3,500 males, is an X-linked recessive disorder result-
ing from a disabling mutation of the gene encoding dys-
trophin, a sarcolemmal protein found in skeletal and
cardiac muscles [1,2]. There is progressive skeletal mus-
cle weakness with loss of ambulatory ability in the teen-
age years. Death is usually due to cardiac or respiratory
failure [3,4], and distinctivep a t h o l o g i cf i n d i n g sh a v e
been noted [5,6]. With improvements in overall manage-
ment and respiratory treatment [7], there has been
increasing interest in the prevention and treatment of
cardiac disease in DMD [8].
Cardiovascular magnetic resonance (CMR) has
recently been investigated as a means to characterize
the cardiac abnormalities of DMD [9-12]. In addition to
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cardial tissue tagging (MTT) [13,14] and late gadolinium
enhancement (LGE) [15] accurately assesses circumfer-
ential strain (Ecc) and scar, the latter being associated
with increased arrhythmia risk and poor cardiac out-
comes [16-18] in heart failure.
The prevalence and distribution of regional myocardial
scar relative to regional Ecc in DMD is not well under-
stood and has important implications for our under-
standing of myocardial dysfunction in DMD. Ecc is a
sensitive indicator of occult myocardial dysfunction in
DMD [9], and average mid-cavity Ecc has been shown
to deteriorate with age in DMD [11,12]. In one study of
DMD and Becker muscular dystrophy patients, regional
myocardial scar was compared with qualitative regional
function as assessed by visual inspection [10], but not
with regional Ecc. In the present series, we provide a
detailed segment-by-segment comparison of Ecc and
scar in DMD patients with a broad range of age and
global left ventricular (LV) function to address the
hypothesis that the strength of the association between
depressed segmental Ecc and scar in DMD depends on
the myocardial region being evaluated.
The study also sought to assess whether velocity vector
imaging (VVI) assessment of Ecc would have some utility
in DMD. VVI echocardiography offers far more advanced
technology than that used in the original echocardio-
graphic studies in DMD patients [19]. VVI assesses Ecc
from echocardiographic short-axis images and has been
studied in both adults and children referred for cardiac
resynchronization therapy [20,21], as well as patients
after myocardial infarction [22]. Although CMR is con-
sidered the gold standard for assessment of myocardial
scar and regional Ecc, a complete CMR examination with
LGE and regional strain assessment may be difficult for
some patients with DMD due to reasons such as respira-
tory insufficiency, severe contractures, intolerance of
recumbent immobility for the time necessary, difficulties
with intravenous access, and limited capacity for coop-
eration if there is impaired cognition. Traditional echo-
cardiographic evaluation in DMD is known to be limited
by suboptimal imaging windows, but whether VVI pro-
vides useful information in selected patients with DMD
has not been determined.
Methods
Enrolment of participants
The protocol was approved by the Johns Hopkins Insti-
tutional Review Board and carried out in the General
Clinical Research Center of the Johns Hopkins Hospital.
CMR protocol
All patients underwent CMR studies using a 1.5-T clini-
cal scanner (Magnetom Avanto, Siemens, Malvern, PA)
with a phase array receiver coil on the chest. Cine
images were acquired using a steady-state free preces-
sion pulse sequence with the following parameters: tem-
poral resolution: 40 ms, echo time: 1.27 ms, flip angle: a
= 50°, field of view: 36 cm, slice thickness: 8 mm, matrix
size: 256 × 161, and bandwidth: 930 Hz/pixel.
Myocardial tagging was performed using an electro-
cardiogram-triggered spoiled gradient echo pulse
sequence with spatial modulation of magnetization grid-
tagging. Short-axis slices were acquired at the left ven-
tricular base, mid-cavity, and apex with the following
parameters: repetition time: 3.5-7.2 ms, echo time: 2.0-
4.2 ms, flip angle: a = 12°, field of view: 40 cm, slice
thickness: 8 mm, matrix size: 256 × 140, bandwidth: 275
Hz/pixel, and tag spacing: 7 mm.
LGE images in locations identical to the cine images
were acquired 10-15 minutes after a bolus of 0.2 mmol/
kg gadodiamide (Omniscan, GE Healthcare, Buckin-
ghamshire, United Kingdom) or gadopentetate dimeglu-
mine (Magnevist, Bayer Healthcare Pharmaceuticals,
Tarrytown, New York) in all patients. An inversion
recovery fast gradient-echo pulse sequence was used for
the acquisition with the following parameters: repetition
time: 5.4 ms, echo time: 1.3 ms, flip angle: a = 20°, field
o fv i e w :3 6 - 4 0c m ,s l i c et h i c kness: 8 mm, matrix size:
256 × 192, and inversion recovery time: 250 ms
(adjusted to null the signal of normal myocardium).
Strain and volumetric analysis
Short axis tagged slices were analyzed in blinded fashion
by the harmonic phase (HARP) method to assess strain
(Diagnosoft, Cary, NC). Segmental peak systolic strains
were determined in 24 segments for basal and mid left
ventricular slices. These were then grouped and averaged
to provide average peak strain values for each of 6 seg-
ments in basal and mid-cavity slices (anteroseptal, ante-
rior, anterolateral, inferolateral, inferior, inferoseptal).
Thus, for each patient, we report the peak circumferen-
tial systolic strain in six myocardial regions at both basal
and mid-cavity myocardium. Left ventricular end-systolic
volume (LVESV) and left ventricular end-diastolic
volume (LVEDV) were measured, and left ventricular
ejection fraction (LVEF) calculated for each study patient.
The strain analysis was performed by two experienced
investigators (KCB, DP), and interobserver variability for
segmental strain was determined for 60 segments (30
basal and 30 mid-cavity segments) acquired from 5 study
participants (12 segments/participant).
Scar analysis
LGE images were analyzed, and abnormally enhanced
myocardium was determined based on prior methods
[17,23] at six circumferential regions in both basal and
mid-cavity slices, corresponding to the segments that
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scar was determined based on established methodology
[16] using the percent of total myocardial thickness at
each segment (no scar, 1-25%, 26-50%, >50%). Left ven-
tricular scar volume was determined as a percentage of
left ventricular volume, as previously described [24].
Segmental scar was evaluated by two independent
observers (KCB, MS).
Echocardiographic analysis
2-dimensional echocardiographic images were acquired
using either GE Vivid 7 or Siemens Acuson machines
and stored digitally at 30 frames per second (Syngo, Sie-
mens). On a separate workstation (Syngo Workplace,
Siemens), VVI (Velocity Vector Imaging, Siemens) was
used to determine peak Ecc. The endocardial border
was manually traced at end-systole in the parasternal
short axis view at the level of the papillary muscles, cor-
responding to the mid-cavity left ventricle, by a single
researcher (WRT) without knowledge of the CMR data.
A single cardiac cycle was selected for analysis. The
software generated a vector for each frame in the car-
diac cycle at 48 points along the endocardial border and
calculated Lagrangian strain at each location. MATLAB
(The MathWorks, Inc.) was used to find the peak (most
negative) strain value for each point, and the average
peak values from 8 consecutive points in each of the six
segments in the mid-cavity left ventricle were calculated.
Neuromuscular evaluation
All but one subject had quantitative hand-held myome-
try evaluation of bilateral elbow and knee flexion and
extension strength within two months of the time of
cardiac evaluation. Strength was determined in units of
pounds as the average of these myometry measurements
for muscle groups associated with the elbow and knee.
An overall composite strength score of 0 indicates that
patients were not capable of any movement in these
muscle groups, although they may have some strength
in the distal extremities.
Statistical methods
Continuous and categorical variables were reported as
the median and interquartile range (IQR). Chi square
tests and Fisher exacts tests were used to compare pro-
portions among groups. We used t-tests for compari-
sons between continuous strain variables. Linear
regression was used to determine associations between
selected continuous variables, with the Pearson correla-
tion coefficient (r) and p-values reported. The intraclass
correlation coefficient (ICC) and associated 95% confi-
dence interval were determined for the analysis of inter-
observer variability of segmental strain (SAS 9.2, SAS
Institute Inc.), as previously reported [25].
Results
Overall characteristics of study population
16 DMD subjects were enrolled (age range 8-23), with
individual clinical characteristics shown in Table 1. The
table shows that patients over a broad age range were
included and had varying degrees of neuromuscular
impairment. As expected, myometry-based strength
measurements tended to worsen with age (r = -0.68; p <
0.01), with very significant limitations observed for some
patients. LVEF also varied significantly in these patients
from 0.28 to 0.69.
Although echo studies were performed in all patients,
two patients (ages 12 and 13) could not tolerate the
CMR due to limited cooperation in one and contrac-
tures that prevented positioning in the MRI chamber in
the second, and LGE could not be performed in another
patient due to difficulty with venous access. Thus a total
of 14 subjects had CMR, and 13 had LGE studies. Scar
was rare in apical segments, so the analysis was per-
formed in the basal and mid-cavity segments for Ecc
and scar, based on a 12-segment model (equivalent to
the basal and mid-cavity segments of a standard 17-seg-
ment model). Comparative analyses of scar and strain
were performed both at the level of individual segments
(n = 156) and on the basis of individual patients.
CMR analysis of regional strain and scar
For the segmental analysis, 156 segments were analyzed
for scar and Ecc by CMR. Aggregate results for scar and
average Ecc by patient are shown in Table 2. There was









8 0 6 . 0.6
9 0 8 14.3 3.0
10 1 3 10.3 1.6
11 0.5 6 6.3 1.0
12 3 0 0 0.6
12 0 6 14.8 0.7
13 2 5 12.8 1.6
13 0 2 2.0 0.8
15 8 0 0 0.5
15 6 8 1.0 0.9
16 5 7 3.0 1.0
17 8 15 0.3 2.0
20 12 0 0 2.4
20 3 0 0 0.5
22 12 1 0 0.8
23 8 18 0.5 0.8
*Indicates average myometry readings for muscle groups associated with the
knee and elbow.
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intraclass correlation coefficient of 0.94 [0.90-0.96], con-
sistent with the previously high reported reliability of
Ecc measurements derived from MTT [25]. In addition,
there was also a 95% agreement between independent
observers with respect to whether segments did or did
not have scar. Scar typically involved at least the subepi-
cardium with a predominant distribution in inferior,
inferolateral, and anterolateral segments, as shown in
the example in Figure 1. 24% of segments had scar pre-
sent by LGE with about a third each having 1-25%
transmurality, 26-50% transmurality, and greater than
50% transmurality, respectively. Scar was present
in both basal and mid-cavity segments, as shown in
Figure 2. 89% of segments with any detectable scar were
either inferior, inferolateral, or anterolateral segments
(group 1), and the remaining 11% of segments with scar
were either inferoseptal, anteroseptal, or anterior seg-
ments (group 2); therefore, scar was eight times more
common in group 1 (lateral) segments compared with
group 2 (septal) segments (p < 0.001). Of note, patients
with scar in septal segments also had significant scar
involving inferolateral segments.
The mean Ecc for segments in groups 1 and 2 were
similar (p = NS). However, the relationship between
segmental Ecc and scar was complex. As shown in
Figure 3A, CMR Ecc in the highest quartile (quartile 4,
most negative) for all segments excluded scar. Segments
in Ecc quartile 1 (least negative, most abnormal strain)
had the highest proportion (46%) with evidence of LGE,
while 33% of Ecc quartile 2 segments and 15% of quar-
tile 1 segments had evidence of scar by LGE (p < 0.001
for differences in scar prevalence by quartile). Figure 4
shows an increased proportion of scar in group 1 (lat-
eral) segments versus group 2 (septal) segments that
w a sc o n s i s t e n ta c r o s sC M REcc quartiles (quartile 1:
76% versus 11%, p = 0.001; quartile 2: 65% versus 9%,
p < 0.001; quartile 3: 38% versus 0%, p < 0.001). These
findings are consistent with a regionally dependent
strength of association between depressed segmental Ecc
and scar.
The relationship between the transmurality of scar and
circumferential strain by CMR and echocardiography is
shown in Figure 5. Panel A describes the relationship
between scar transmurality and CMR-based Ecc. Seg-
ments with the most transmural scar were in the lowest
quartile of Ecc (quartile 1) by CMR, while segments with
intermediate scar transmurality were distributed between
Ecc quartiles 1 and 2. With respect to echocardiography,
segments with more transmural scar tended to be in the
lowest two echo Ecc quartiles (quartiles 1 and 2), while
segments with the least transmural scar corresponded
mostly to echo Ecc quartile 3.
Table 2 Overall Summary of CMR findings
Median IQR
LVEF 0.52 (0.45, 0.57)
LVEDV (cc) 68 (64,97)
CMR Base Ecc (%) -13.3 (-10.0,-16.4)
CMR Mid-cavity Ecc (%) -13.7 (-11.0,-16.9)
Echo Mid-cavity Ecc (%) -15.0 (-9.9,-19.8)
Percent Scar Volume (%) 6 (0,10)
IQR = Interquartile Range.
A                                  B
Figure 1 DMD late gadolinium enhancement. Basal (panel A) and mid-cavity (panel B) slices of subepicardial and midmyocardial scar
involving inferolateral and anterolateral segments in a patient with DMD. The white (hyperenhanced) region (arrow) is scar, while the black
represents normal myocardium.
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VVI analysis for regional Ecc by echo could be per-
formed in only 12 of the 14 patients who had CMR and
only in mid-cavity rather than basal segments. As
shown in Table 2, the medians for echo and CMR mid-
cavity Ecc were similar; however, the correlation
between echo and CMR assessments of segmental Ecc
was limited (r = 0.27; p = 0.02). As shown in Figure 3B,
segments with echo Ecc in the highest quartile pre-
dicted absence of scar, whereas segments with scar were
distributed in the lower three (more dysfunctional)
quartiles of echo Ecc.
Overall measures of function relative to scar burden
54% of patients had evidence of late gadolinium enhance-
ment in at least one segment, and in all patients with scar
the abnormality involved at least the lateral segments.
Those with scar had a mean percent scar volume of 13%
(range 6-29%). There was an inverse correlation between
LVEF by CMR and the percent scar volume (r = -0.68, p =
0.01). Although scar was common in patients with moder-
ately and severely reduced LVEF, some patients with only
mildly reduced LVEF also were noted to have scar. Percent
scar volume also correlated with average peak CMR strain
in basal (r = 0.75, p < 0.01) and mid-cavity (r = 0.74, p <
0.01) segments.
Electrocardiographic findings
Analysis of the 12-lead ECG was performed for all
patients. All patients had an R wave in lead V1 with
amplitude ranging from 4-19 mV. Small q waves were
present in lead I and aVL in most patients, but only one
patient had prominent Q waves in leads I and aVL. Sev-
eral ECG parameters were examined for prediction of
Figure 2 Distribution of myocardial scar in basal and mid-
cavity segments. The bar graph shows inferolateral, inferior, and
anterolateral predominance of scar, as well as the distribution of
scar between basal and mid-cavity segments. Ant-Lat =
anterolateral; Inf-Lat = inferolateral; Inf-Sept = inferoseptal;
Ant-Sept = anteroseptal.
Figure 3 Segmental scar and circumferential strain by CMR
versus VVI echocardiography. The distribution of myocardial
fibrosis by quartile of Ecc as assessed with (A) CMR (all segments) or
(B) VVI echocardiography (mid-cavity segments only) is shown. A)
No segments with Ecc by CMR in the fourth (most negative)
quartile had myocardial scar. Myocardial scar was most common in
the two lowest (most dysfunctional) Ecc quartiles. B) Scar was also
unlikely in segments falling into the fourth quartile of Ecc as
assessed by echo VVI and was distributed in the lower three echo
Ecc quartiles. 1
st quartile = least negative Ecc (most dysfunctional);
4
th quartile = most negative Ecc.
Figure 4 I n c r e a s e dp r o p o r t i o no fs c a ri nl a t e r a lv e r s u ss e p t a l
segments across CMR circumferential strain quartiles. The figure
shows an increased proportion of scar in group 1 (lateral) segments
versus group 2 (septal) segments based on the analysis of all 156
myocardial segments. This effect was consistent across all lower
three CMR quartiles of Ecc, indicating that there is increased
prevalence of segmental scar at any level of segmental Ecc in group
1 (lateral) segments versus group 2 (septal) segments. In other
words, the association between depressed Ecc and scar has a
significant regional dependence, with dysfunctional lateral segments
much more likely to have scar than dysfunctional septal segments.
1
st quartile = least negative Ecc (most dysfunctional); 4
th quartile =
most negative Ecc.
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V1, the R/S ratio in lead V1, and Q wave presence in
leads I and aVL, but none demonstrated significant pre-
dictive value for scar. R/S ratios in V1 for individual
patients are shown in Table 1.
Discussion
The important findings of this study include the follow-
ing: 1) segmental basal or mid-cavity Ecc by CMR in the
highest quartile makes regional myocardial scar highly
unlikely; 2) segmental scar is much more common in
inferolateral, anterolateral, or lateral segments with
depressed Ecc than in inferoseptal, anteroseptal, and
anterior segments with depressed Ecc, consistent with a
regionally dependent strength of association between
depressed segmental Ecc and scar; 3) echocardiographic
segmental mid-cavity Ecc based on velocity vector ima-
ging in the highest quartile also makes scar (by CMR) in
the corresponding segment unlikely, but there was only
a limited correlation for mid-cavity segmental Ecc
assessed using the two modalities.
The importance of assessing and understanding myo-
cardial scar and function in DMD has taken on
increased clinical relevance with recent evidence that
medical therapy with antifibrotic agents such as angio-
tensin converting enzyme inhibitors [8], angiotensin
receptor blockers [26], and membrane sealants [27] may
help prevent or slow the progression of cardiac disease
in DMD. Our findings regarding scar are consistent
with findings from earlier autopsy studies in DMD
showing that myocardial fibrosis initially involves the
“posterobasal” epicardium, progresses to involve the epi-
cardial half of the LV free wall, then occasionally
involves septal segments as the fibrosis becomes more
severe and more transmural [5].
Although autopsy studies and CMR both provide
excellent assessments of myocardial scar, CMR has the
advantage of also providing quantitative regional assess-
ment of myocardial function with Ecc. Of note, circum-
ferential strain has been better studied in DMD than
radial or longitudinal strain [9,10]. Ecc is also particu-
larly well suited for evaluation of affected LV segments
in DMD because left ventricular myofiber orientation is
predominantly circumferential [28], and its use has been
established for mechanical function in heart failure
[29,30].
As in prior autopsy studies, we found that scar pre-
dominantly involved LV free wall segments and that
septal segments were involved less frequently and only
in patients with significant LV free wall involvement.
In addition, the present study shows that there were
similar numbers of LV septal and free wall segments
with depressed Ecc; however, the septal segments with
abnormal Ecc values were much less likely to have
myocardial scar than free wall segments with similarly
abnormal Ecc values. Although the pathophysiologic
mechanism behind this curious tendency for the septal
segments to become dysfunctional without scar and
LV free wall segments to become dysfunctional with
scar is unknown, TGF-b has emerged as the major
likely effector of fibrosis in DMD. TGF-b inhibits
terminal differentiation of myoblasts and is associated
with the development of peripheral muscle fibrosis in
DMD [31]. Losartan (an angiotensin II receptor
blocker) has been shown to counteract the effects of
TGF-b, decrease muscle fibrosis, and improve muscle
regeneration in mdx mice [32]. In addition, perindopril
(an angiotensin converting enzyme inhibitor) has been
shown to decrease the risk of developing LV systolic
dysfunction in patients with DMD when started at a
young age [8]. Although it is unknown if and how
regional differences in these molecular pathways result
Figure 5 Relationship between segmental transmurality of scar
and regional Ecc. The relationship between the segmental
transmurality of scar (characterized as 0-25% transmural, 26-50%
transmural, or >50% transmural) and regional Ecc is shown, with
regional Ecc characterized by (A) CMR (all segments), and (B) VVI
echocardiography (mid-cavity segments only). Note that all
segments with scar of greater than 50% transmurality were in the
most dysfunctional CMR Ecc quartile (Q1), and segments with
intermediate scar transmurality were distributed among the lower
two Ecc quartiles (Q1 and Q2).
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been shown that regional differences in LV wall
mechanics can result in differential expression of genes
related to matrix remodeling and hypertrophy in other
cardiac disease states [33].
Our findings regarding Ecc and scar complement
those reported by Silva et al in a series of 10 DMD or
Becker muscular dystrophy patients with regional dys-
function assessed by visual inspection rather than Ecc
[10]. In the series of Silva et al, a small number of seg-
ments with apparently normal function had positive
LGE, indicating that the prevalence of scar in segments
with normal segmental function depends on whether
visual inspection or Ecc is used to define normal
function.
Of note, we analyzed Ecc in this study using the well-
validated HARP method [13] and demonstrated good
interobserver agreement for Ecc, consistent with the
demonstrated reliability of this method for Ecc analysis
[25]. Furthermore, our average and range for Ecc were
consistent with what has been previously reported. For
example, the median mid-cavity peak Ecc was within 1%
of the mean Ecc reported in a recent series [34]. In
addition, our range for mid-cavity Ecc was consistent
with the range for mid-cavity Ecc reported in a series of
young DMD patients [9].
With respect to VVI echocardiography, adequate
echocardiographic strain data could not be obtained in
all DMD patients due to limited echocardiographic
windows, and the analysis had to be limited to mid-
cavity segments. Although normal segmental Ecc by
echo predicted absence of scar in the corresponding
segment by CMR, the correlation between VVI and
CMR assessments of Ecc in mid-cavity segments was
limited. Based on these results, although VVI echocar-
diographic assessment of regional Ecc in DMD was
feasible, it does not appear to be an adequate surrogate
in DMD for CMR with MTT, which is presently
regarded as the gold standard for myocardial Ecc
[13,35].
With respect to electrocardiography, although there
may be clues in the 12-lead electrocardiogram sugges-
tive of more advanced cardiac disease and scar, we were
unable to identify a specific predictor relative to CMR
findings, highlighting the importance of accurate and
feasible cardiac imaging for this purpose.
Conclusions
The relationship between scar and Ecc in DMD is com-
plex. Among myocardial segments with depressed Ecc,
scar prevalence was much higher in inferior, inferolat-
eral, and anterolateral segments, indicating a regionally
dependent association between abnormal Ecc and scar.
As a result, LV septal segments are more likely to
develop abnormal Ecc without scar in DMD, whereas
abnormal Ecc is commonly associated with scar in LV
free wall segments. With respect to echocardiography,
although normal segmental Ecc by VVI is associated
with absence of scar, VVI assessment of abnormal regio-
nal echocardiographic Ecc was only weakly associated
with CMR Ecc in DMD.
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